Medico Remedies Limited (NSE:MEDICO)
53.80
-0.11 (-0.20%)
May 23, 2025, 3:29 PM IST
Medico Remedies Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 10.95 | 1.83 | 9.11 | 23.44 | 28.3 | Upgrade
|
Short-Term Investments | 14.51 | 13.63 | 12.66 | - | 10.6 | Upgrade
|
Cash & Short-Term Investments | 25.46 | 15.46 | 21.77 | 23.44 | 38.9 | Upgrade
|
Cash Growth | 64.67% | -29.00% | -7.12% | -39.75% | 173.86% | Upgrade
|
Accounts Receivable | 571.81 | 496.33 | 360.95 | 303.94 | 274.2 | Upgrade
|
Other Receivables | - | 54.39 | 58.77 | 64.05 | 121.8 | Upgrade
|
Receivables | 573.67 | 552.68 | 421.24 | 369.57 | 397.6 | Upgrade
|
Inventory | 267.26 | 163.37 | 196.99 | 181.08 | 145.5 | Upgrade
|
Prepaid Expenses | - | 1.75 | 1.06 | 0.97 | 0.8 | Upgrade
|
Other Current Assets | 100.37 | 4.39 | 4.34 | 0.68 | 2 | Upgrade
|
Total Current Assets | 966.75 | 737.65 | 645.39 | 575.73 | 584.8 | Upgrade
|
Property, Plant & Equipment | 215.81 | 213.74 | 218.3 | 180.34 | 153.1 | Upgrade
|
Long-Term Investments | 2 | 2.03 | - | - | 1.1 | Upgrade
|
Other Intangible Assets | 0.66 | 1.21 | 0.7 | - | - | Upgrade
|
Long-Term Deferred Tax Assets | 2.48 | - | - | 1.86 | - | Upgrade
|
Other Long-Term Assets | 10.3 | 7.34 | 10.09 | 16.12 | 17.2 | Upgrade
|
Total Assets | 1,198 | 961.95 | 874.48 | 774.04 | 756.2 | Upgrade
|
Accounts Payable | 347.13 | 315.12 | 309.86 | 270.97 | 236.9 | Upgrade
|
Accrued Expenses | - | 14.38 | 9.58 | 4.29 | 22 | Upgrade
|
Short-Term Debt | 138.32 | 67.52 | 80.93 | 90.64 | 81.1 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 6.5 | 19.9 | Upgrade
|
Current Portion of Leases | 4.98 | 4.31 | 3.7 | 3.13 | - | Upgrade
|
Current Income Taxes Payable | 17.02 | 11.16 | 8.64 | 3.62 | 1.2 | Upgrade
|
Other Current Liabilities | 62.15 | 15.65 | 4.99 | 2.25 | 18.4 | Upgrade
|
Total Current Liabilities | 569.62 | 428.14 | 417.7 | 381.4 | 379.5 | Upgrade
|
Long-Term Debt | - | - | - | 9.02 | 49.5 | Upgrade
|
Long-Term Leases | 3.69 | 8.67 | 12.99 | 16.68 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 1.43 | 1.86 | - | 1.6 | Upgrade
|
Other Long-Term Liabilities | 0 | -0 | 2.88 | 0.72 | - | Upgrade
|
Total Liabilities | 573.3 | 438.24 | 436.05 | 408.3 | 431.6 | Upgrade
|
Common Stock | 165.97 | 165.97 | 165.97 | 165.97 | 41.5 | Upgrade
|
Additional Paid-In Capital | - | 33.32 | 33.32 | 33.32 | 158.1 | Upgrade
|
Retained Earnings | - | 322.07 | 239.16 | 166.75 | 125 | Upgrade
|
Comprehensive Income & Other | 458.72 | 2.36 | -0.02 | -0.28 | - | Upgrade
|
Shareholders' Equity | 624.69 | 523.71 | 438.43 | 365.75 | 324.6 | Upgrade
|
Total Liabilities & Equity | 1,198 | 961.95 | 874.48 | 774.04 | 756.2 | Upgrade
|
Total Debt | 147 | 80.5 | 97.62 | 125.97 | 150.5 | Upgrade
|
Net Cash (Debt) | -121.54 | -65.05 | -75.85 | -102.53 | -111.6 | Upgrade
|
Net Cash Per Share | -1.47 | -0.78 | -0.91 | -1.24 | -1.34 | Upgrade
|
Filing Date Shares Outstanding | 83.48 | 82.98 | 82.98 | 82.98 | 82.98 | Upgrade
|
Total Common Shares Outstanding | 83.48 | 82.98 | 82.98 | 82.98 | 82.98 | Upgrade
|
Working Capital | 397.14 | 309.5 | 227.69 | 194.33 | 205.3 | Upgrade
|
Book Value Per Share | 7.48 | 6.31 | 5.28 | 4.41 | 3.91 | Upgrade
|
Tangible Book Value | 624.03 | 522.51 | 437.73 | 365.75 | 324.6 | Upgrade
|
Tangible Book Value Per Share | 7.48 | 6.30 | 5.27 | 4.41 | 3.91 | Upgrade
|
Land | - | 23.08 | 23.08 | 23.08 | 9.8 | Upgrade
|
Buildings | - | 156.03 | 153.56 | 132.92 | 156.1 | Upgrade
|
Machinery | - | 212.18 | 190.61 | 147.17 | 122.9 | Upgrade
|
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.